Alpha Tau Medical (DRTS) Total Non-Current Liabilities (2020 - 2026)

Alpha Tau Medical (DRTS) has reported Total Non-Current Liabilities for 7 consecutive years, with $29.0 million the latest figure, recorded in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 95.28% year-over-year to $29.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.0 million (up 95.28% YoY) and the FY2025 annual result came in at $18.0 million, up 21.42% from the prior year.
• Total Non-Current Liabilities climbed to $29.0 million in Q1 2026 per DRTS's latest filing, from $18.0 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for DRTS reached as high as $29.0 million in Q1 2026 and fell as low as $8.1 million in Q1 2022.
• A 5-year average of $15.2 million and a median of $15.0 million in 2024 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 196.19% — and 2025, when it retreated 9.41%.
• Year by year, Total Non-Current Liabilities stood at $10.2 million in 2022, then soared by 55.71% to $15.8 million in 2023, then retreated by 6.0% to $14.9 million in 2024, then grew by 21.42% to $18.0 million in 2025, then jumped by 60.55% to $29.0 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $29.0 million, $18.0 million, and $18.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.